2nd Quarter - Amendment

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2025 $50,000 Replaced
2nd Quarter - Amendment (this page) Jul 23, 2025 $60,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. Priority Review Voucher Reauthorization. Newborn Screening.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
VICTORIA GEMME —
ALLISON HERRITY —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
VICTORIA GEMME —
ALLISON HERRITY —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. H.R.1414: Camerons Law. Promising Pathways Act 2.0.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
VICTORIA GEMME —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1414 (119th)

Budget/Appropriations BUD

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. Advanced Research Projects Agency - Health (ARPA-H) Appropriations. NIH / FDA Appropriations. HHS RIFs.

LobbyistCovered position, as disclosed
HAYLEY DEMPSEY —
VICTORIA GEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.